What is SciClone Pharmaceuticals (Holdings) Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. SciClone Pharmaceuticals (Holdings)'s Average Total Inventories for the quarter that ended in Dec. 2023 was HK$232 Mil. SciClone Pharmaceuticals (Holdings)'s Revenue for the
six
months ended in Dec. 2023 was HK$1,698 Mil.
SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.14.
SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue for the quarter that ended in Dec. 2023
increased
from Jun. 2023 (0.08) to Jun. 2023 (0.14)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
SciClone Pharmaceuticals (Holdings)'s Days Inventory for the
six
months ended in Dec. 2023 was 98.96.
Inventory Turnover measures how fast the company turns over its inventory within a year.
SciClone Pharmaceuticals (Holdings)'s Inventory Turnover for the quarter that ended in Dec. 2023 was 1.84.
SciClone Pharmaceuticals (Holdings) Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
SciClone Pharmaceuticals (Holdings)'s Days Inventory for the
six
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciClone Pharmaceuticals (Holdings) Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
SciClone Pharmaceuticals (Holdings) (HKSE:06600) Business Description
SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, primarily including oncology and severe infection. It generated revenue primarily from the sale of Zadaxin to Sinopharm.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06600 has been successfully added to your 